Literature DB >> 27942835

Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers.

Patrick Carlier1, Maritza Markarian, Nathalie Bernard2, Laurence Lagarce3, Anne Dautriche4, Johana Béné5, Nathalie Fouilhé Sam-Lai6, Pirayeh Eftekhari7.   

Abstract

Entities:  

Year:  2016        PMID： 27942835     DOI： 10.1007/s00404-016-4262-z

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN： 0932-0067            Impact factor:   2.344


× No keyword cloud information.
  2 in total

Review 1.  Fertility considerations in targeted biologic therapy with tyrosine kinase inhibitors: a review.

Authors:  Anupama Rambhatla; Michael R Strug; Jessica Garcia De Paredes; Marcos I Cordoba Munoz; Mili Thakur
Journal:  J Assist Reprod Genet       Date:  2021-04-07       Impact factor: 3.357

2.  Multidisciplinary consensus on the criteria for fertility preservation in cancer patients.

Authors:  A Santaballa; C Márquez-Vega; Á Rodríguez-Lescure; Á Rovirosa; L Vázquez; I Zeberio-Etxetxipia; M Andrés; L Bassas; E Ceballos-Garcia; J Domingo; D Manau-Trullas
Journal:  Clin Transl Oncol       Date:  2021-10-11       Impact factor: 3.405
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.